Dr. Newcomer focuses his time on innovations that improve the care delivery and affordability of cancer care and genomics. He is a medical oncologist who practiced for ten years. He then spent the majority of his career with UnitedHealth Group where he served as the Chief Medical Officer for 10 years followed by an additional 14 years dedicated to oncology and genetics. During that period he launched the first oncology value based contract and the first commercial cancer database with claims and clinical data. Dr. Newcomer chaired the board of directors at Park Nicollet Clinic, a 1000+ physician and 400 hospital bed integrated delivery provider In Minneapolis. He is currently a director at Myriad Genetics, Cellworks, and Intervention Insights.
At some point in the future, an individual’s genome will be a foundational part of their medical record. Driving towards precision medicine involves increasingly comprehensive sequencing and arrays, access to standardized testing, integration into systems used by health care providers to manage patients, and building evidence that genomic information has clinical utility and can be used to improve outcomes. Sustainable incorporation of genomics into routine care requires efficient testing, readily accessible genomic data and decision support, and data aggregation that can assess patient outcomes. In this session, various stakeholders, including both healthcare (large, integrated healthcare systems), healthcare information technology, and insurance providers, will share their perspectives on current approaches and the challenges they observe on achieving this goal.